Waters Corporation (WAT)
| Market Cap | 31.67B +30.9% |
| Revenue (ttm) | 3.17B +7.0% |
| Net Income | 642.63M +0.8% |
| EPS | 10.76 +0.5% |
| Shares Out | 98.10M |
| PE Ratio | 30.00 |
| Forward PE | 22.43 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,232,358 |
| Open | 321.14 |
| Previous Close | 319.44 |
| Day's Range | 314.40 - 322.98 |
| 52-Week Range | 275.05 - 414.15 |
| Beta | 1.18 |
| Analysts | Buy |
| Price Target | 386.59 (+19.75%) |
| Earnings Date | Feb 9, 2026 |
About WAT
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, and other consumable products. It designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments,... [Read more]
Financial Performance
In 2025, Waters's revenue was $3.17 billion, an increase of 6.99% compared to the previous year's $2.96 billion. Earnings were $642.63 million, an increase of 0.75%.
Financial StatementsAnalyst Summary
According to 18 analysts, the average rating for WAT stock is "Buy." The 12-month stock price target is $386.59, which is an increase of 19.75% from the latest price.
News
Waters Corporation to Present at the TD Cowen Health Care Conference
MILFORD, Mass., Feb. 23, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D.
Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage
Headlines: Delivers up to 2× higher sensitivity than stainless steel microflow columns, lowering detection and quantitation limits across high-throughput bioseparations, DMPK, and 'omics applications....
Why Is Waters Stock Sinking Monday?
Waters Corporation (NYSE: WAT) stock is trading lower on Monday after the company released fourth-quarter 2025 financial results and issued fiscal 2026 guidance.
Waters Corporation (WAT) Q4 2025 Earnings Call Transcript
Waters Corporation (WAT) Q4 2025 Earnings Call Transcript
BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation
FRANKLIN LAKES, N.J., Feb. 9, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) today announced the successful completion of the previously announced spin-off of BD's Biosciences & D...
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses
Announces appointment of Claire M. Fraser, Ph.D.
Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2025 Financial Results
Highlights Fourth Quarter 2025 Sales of $932 million landed at the high-end of reported sales growth guidance range; grew 7% as reported and 6% in constant currency Growth led by high single-digit con...
Waters Corporation: Bigger, Better, But Fairly Priced
Waters Corporation: Bigger, Better, But Fairly Priced
BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business
Distribution date and closing date for spin-off and merger with Waters Corporation set for February 9, 2026 FRANKLIN LAKES, N.J., Jan. 27, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE...
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business
Waters Corporation's Q4 2025 Financial Results Conference Call will now be held on Monday, February 9th, 2026 at 8:30am ET in conjunction with the expected close of the transaction MILFORD, Mass., Ja...
Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call
MILFORD, Mass., Jan. 20, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q4 2025 financial results conference call on Thursday, February 12th, 2026 at 8:00 a.m.
Artisan Mid Cap Fund Q4 2025 Performance Discussion And Portfolio Activity
The portfolio delivered a modest negative absolute return during Q4 but outpaced the Russell Midcap® Growth Index by several percentage points. IT was an area of strength during the quarter, led by ho...
Waters Corporation (WAT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Waters Corporation (WAT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026
MILFORD, Mass., Dec. 23, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will present at the 44th Annual J.P. Morgan ...
Waters Corporation (WAT) Presents at Jefferies London Healthcare Conference 2025 Transcript
Waters Corporation ( WAT) Jefferies London Healthcare Conference 2025 November 18, 2025 9:30 AM EST Company Participants Udit Batra - President, CEO & Director Conference Call Participants Tycho Pete...
Waters Corporation to Present at the Jefferies Global Healthcare Conference in London
MILFORD, Mass. , Nov. 11, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D.
Waters Boosts Lab Productivity and Sample Throughput with Launch of its Charged Aerosol Detector Designed for Empower Software
Drives efficiency and reliability in Quality Control and Development environments, integrating seamlessly with world-class Empower™ Chromatography Data System (CDS). Mitigates CDS communication errors...
The London Company SMID Cap Vs. Russell 2500 Q3 2025 Top Contributors And Detractors
Armstrong World Industries, Inc. (AWI) shares outperformed in the quarter due to beating expectations, driven by favorable positioning in key verticals and strong operating leverage. Somnigroup Intern...
Waters Corporation (WAT) Q3 2025 Earnings Call Transcript
Waters Corporation ( WAT) Q3 2025 Earnings Call November 4, 2025 8:00 AM EST Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President, CEO & Director Amol Chaubal - Senio...
Waters Corp raises annual profit forecast on stronger lab equipment demand
Lab equipment maker Waters Corp raised its annual profit forecast on Tuesday, after beating third-quarter profit estimates on improved demand from biotech clients for its tools used in drug developmen...
Waters Corporation (NYSE: WAT) Reports Third Quarter 2025 Financial Results
Highlights Sales of $800 million exceeded guidance; grew 8% as reported and 8% in constant currency Delivered GAAP EPS of $2.50 and non-GAAP EPS of $3.40, which reflects strong, 16% growth in Adjusted...
Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics
Headlines: Xevo™ CDMS facilitates direct, accurate mass detection for the largest, most heterogeneous biomolecules.1 Enables accurate analysis of protein complexes, nucleic acids, and gene delivery ve...
Waters Corporation Schedules Third Quarter 2025 Earnings Conference Call
MILFORD, Mass. , Oct. 1, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2025 financial results conference call on Tuesday, November 4th, 2025 at 8:00 a.m.
Waters Corporation (WAT) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
Waters Corporation (NYSE:WAT) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 9:30 AM EDT Company Participants Udit Batra - President, CEO & Director Conference Call Participants...
Waters Corporation to Present at the Wells Fargo Healthcare Conference
MILFORD, Mass. , Aug. 26, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D.